Biphosphonate metal complexes as selective inhibitors of Tryanosoma cruzi farnesyl diphosphate synthase

METALES

COMPLEJOS DE METALES

ENFERMEDAD DE CHAGAS

TRIPANOSOMA CRUZI

BIBLIOGRAFIA NACIONAL QUIMICA

2012

In the search for a pharmacological answer to treat Chagas disease, eight metal complexes with two bioactive bisphosphonates, alendronate (Ale) and pamidronate (Pam), were described. Complexes of the formula [M 2 II(Ale) 4(H 2O) 2]·2H 2O, with M = Cu, Co, Mn, Ni, and ([CuPam]·H 2O) n as well as [M II(Pam) 2(H 2O) 2]·3H 2O, with M = Co, Mn and Ni, were synthesized and fully characterized. Crystal structure of [Cu 2 II(Ale) 4(H 2O) 2]·2H 2O, [Co II(Pam) 2(H 2O) 2] and [Ni II(Pam) 2(H 2O) 2] were solved by X-ray single crystal diffraction methods and the structures of [M 2 II(Ale) 4(H 2O) 2] ·2H 2O complexes M = Co, Mn and Ni were studied by X-ray powder diffraction methods. All obtained complexes were active against the amastigote form of Trypanosoma cruzi (T. cruzi), etiological agent of Chagas disease. Most of them were more active than the corresponding free ligands showing no toxicity for mammalian cells. The main mechanism of the antiparasitic action of bisphosphonates, inhibition of parasitic farnesyl diphosphate synthase (TcFPPS), remains in the obtained metal complexes and an increase in the inhibiting enzyme levels was observed upon coordination. Observed enzymatic inhibition was selective for TcFPPS as the metal complexes showed no or little inhibition of human FPPS. Additionally, metal complexation might improve the bioavailability of the complexes through the hindrance of the phosphonate group's ionization at physiological pH and, eventually, through the ability of plasma proteins to work as complex transporters.

Dalton Transactions v. 41, no. 21, 2012. -- p. 6468-6476

Royal Society of Chemistry

2012

Información sobre Derechos de Autor

(Por favor lea este aviso antes de abrir los documentos u objetos)

La legislación uruguaya protege el derecho de autor sobre toda creación literaria, científica o artística, tanto en lo que tiene que ver con sus derechos morales, como en lo referente a los derechos patrimoniales con sujeción a lo establecido por el derecho común y las siguientes leyes

(LEY 9.739 DE 17 DE DICIEMBRE DE 1937 SOBRE PROPIEDAD LITERARIA Y ARTISTICA CON LAS MODIFICACIONES INTRODUCIDAS POR LA LEY DE DERECHO DE AUTOR Y DERECHOS CONEXOS No. 17.616 DE 10 DE ENERO DE 2003, LEY 17.805 DE 26 DE AGOSTO DE 2004, LEY 18.046 DE 24 DE OCTUBRE DE 2006 LEY 18.046 DE 24 DE OCTUBRE DE 2006)

ADVERTENCIA - La consulta de este documento queda condicionada a la aceptación de las siguientes condiciones de uso: Este documento es únicamente para usos privados enmarcados en actividades de investigación y docencia. No se autoriza su reproducción con fines de lucro. Esta reserva de derechos afecta tanto los datos del documento como a sus contenidos. En la utilización o cita de partes debe indicarse el nombre de la persona autora.

 

 

PDF

Inglés

Artículo

ISSN: 14779226

DOI: 10.1039/c2dt12179d

PDF